Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Dysregulation of regulatory CD56(bright) NK cells/T cells interactions in multiple sclerosis.
Semen quality of 4480 young cancer and systemic disease patients: baseline data and clinical considerations.
Transdermal Application of Myelin Peptides in Multiple Sclerosis Treatment.
Nephrotic-range proteinuria on interferon-β treatment: immune-induced glomerulonephritis or other pathway?
Dimethyl fumarate (BG-12, Tecfidera) - NICE gives initial "no" decision
Information for healthcare professionals: Rituximab
Visualization of myelination in GFP-transgenic zebrafish.
Anti-JCV antibody levels in serum or plasma further define risk of natalizumab-associated PML.
Identical lesion morphology in primary progressive and relapsing-remitting MS -an ultrahigh field MRI study.
G protein-coupled receptor 37 is a negative regulator of oligodendrocyte differentiation and myelination.
Evaluating epigenetic landmarks in the brain of multiple sclerosis patients: a contribution to the current debate on disease pathogenesis.
SigmaPharm Laboratories Products
Ruxolitinib synergizes with DMF to kill via BIM+BAD-induced mitochondrial dysfunction and via reduced SOD2/TRX expression and ROS.
Daclizumab phase II trial in relapsing and remitting multiple sclerosis: MRI and clinical results.
[The effect of flupirtine, various analgesics and muscle relaxants on skeletal muscle tone in the conscious rat].
Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: integrated 2-year results.
Nanoparticle transport across the blood brain barrier.
Newly onset sinus bradycardia in the context of multiple sclerosis relapse.
Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro.
The influence of disease duration, clinical course, and immunosuppressive therapy on the synthesis of intrathecal oligoclonal IgG bands in multiple sclerosis.
Interferon beta-1b in secondary progressive MS: a combined analysis of the two trials.
Oligodendrogenesis and myelinogenesis during postnatal development effect of glatiramer acetate.
Dimethyl fumarate inhibits integrin α4 expression in multiple sclerosis models.
Antioxidative enzymes activity and malondialdehyde concentration during mitoxantrone therapy in multiple sclerosis patients.
Dimethylfumarate protects against TNF-α-induced secretion of inflammatory cytokines in human endothelial cells.

Pages